Navigation Links
Cyberonics Reports Strong Revenue Growth and Profitability in Fiscal 2008 Fourth Quarter
Date:6/11/2008

(Audited)

ASSETS

Current Assets:

Cash and cash equivalents $91,058,692 $84,804,876

Restricted cash 1,000,000 1,000,000

Accounts receivable, net of allowances

of $240,925 and $308,083, respectively 20,039,832 18,914,206

Inventories 12,829,710 17,580,830

Other current assets 2,108,185 3,127,345

Total Current Assets 127,036,419 125,427,257

Property and equipment, net of accumulated

depreciation of $20,935,788 and

$19,606,513, respectively 5,503,139 8,028,037

Other assets 3,691,529 4,189,589

Total Assets 136,231,087 137,644,883

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

Current Liabilities:

Line of credit $- $7,500,000

Accounts payable 2,740,075 5,951,931

Accrued liabilities 14,547,877 14,844,266

Convertible Notes - 125,000,000

Other - 115,731

Total Current Liabilities 17,287,952 153,411,928

Long Term Liabilities:

Convertible Notes 125,000,000 -

Other 9,166,440 295,184

Total Long Term Liabilities 134,166,440 295,184

Total Liabilities 151,454,392 153,707,112

Stockholders' Deficit:

Total Stockholders' Deficit (15,223,305) (16,062,229)

Total Liabilities and Stockholders'

Deficit
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Alfacell Reports Financial Results for Third Quarter of Fiscal 2008
2. YM BIOSCIENCES REPORTS NIMOTUZUMAB NSCLC CLINICAL DATA AT ASCO ANNUAL MEETING
3. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
4. Cord Blood America Reports CorCell, Its Major Acquisition in 2006, Turns Profitable
5. Bioheart, Inc. Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
6. Rosetta Genomics Reports First Quarter 2008 Financial Results
7. Genetic Engineering and Biotechnology News (GEN) Reports on Mass Spec in Drug Discovery
8. Advance Nanotech Reports First Quarter 2008 Financial Results
9. Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results
10. Senetek PLC Reports First Quarter 2008 Financial Results
11. New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barretts Esophagus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014 SRI International has been ... National Institute of Allergy and Infectious Diseases (NIAID), part ... development of potential therapies for HIV infection and AIDS. ... HIV and AIDS and the complications and opportunistic infections ... preventing sexual transmission of HIV. According ...
(Date:7/24/2014)... CA (PRWEB) July 24, 2014 Three ... be semi-finalists in Livestrong’s Big C Competition. Out of ... are each headed to the semi-final round. In this ... exclusive three-month accelerator program, complete with mentoring from thought-leaders ... , As part of the angelMD commitment to the ...
(Date:7/24/2014)... July 24, 2014  Neogen Corporation (Nasdaq: ... of its potential revenue from new rodenticide research are ... and analysts on July 22, 2014, Neogen,s CEO commented ... this research. "It was my intent Tuesday ... potential of a new type of rodenticide, but certainly ...
(Date:7/24/2014)... 1000 balances – 4 steps – ... weighing needs and expertly narrows down the mass of ... or even terminals. , First, select the working ... select readability instead) and define the accuracy – it’s ... narrows down the list to models that fit best ...
Breaking Biology Technology:National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 33 angelMD Startups Make Livestrong Big C Semi-finals 2Neogen comments on SenesTech 2
... ... Prize in Chemistry published papers on their award-winning work based on data collected at the ... ... Nobel Prize in Chemistry published papers on their award-winning work based on data collected at ...
... Inc. (Nasdaq: LXRX ) today announced that it ... conditions, 27,500,000 shares of its common stock pursuant to ... are being offered through the underwriters and 11,087,387 shares ... Lexicon also intends to grant the underwriters a ...
... ... President Obama , ... Argonne, Ill. (Vocus) October 7, 2009 -- The IBM Blue Gene series of energy-efficient ... President Barack Obama as a Medal of Technology and Innovation award-winner on October 7 ...
Cached Biology Technology:Argonne's Advanced Photon Source Lit the Way to Chemistry Nobel 2Argonne's Advanced Photon Source Lit the Way to Chemistry Nobel 3Lexicon Announces Proposed Offering of 27,500,000 Shares of Common Stock 2Lexicon Announces Proposed Offering of 27,500,000 Shares of Common Stock 3DOE Labs Take Pride in Award-Winning IBM Blue Gene Series 2DOE Labs Take Pride in Award-Winning IBM Blue Gene Series 3DOE Labs Take Pride in Award-Winning IBM Blue Gene Series 4
(Date:7/24/2014)... 2014) Scientists at The New York Stem ... closer to creating a viable cell replacement therapy ... , For the first time, NYSCF scientists ... skin samples of patients with primary progressive multiple ... to induce these stem cells into becoming oligodendrocytes, ...
(Date:7/24/2014)... 24, 2014) Scientists at The New York ... step closer to creating a viable cell replacement ... cells. , For the first time, NYSCF ... from skin samples of patients with primary progressive ... protocol to induce these stem cells into becoming ...
(Date:7/24/2014)... two factors that characterize sustainable university and college ... qualified physics teachers. Specifically, one or more faculty ... in combination with institutional motivation and commitment can ... Engineering and Math (STEM) teacher shortages are especially ... way for institutions seeking to increase the number ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Creating sustainable STEM teacher preparation programs 2
... Mich. --- Scientists have discovered a molecular process in ... a target for treatments to prevent or reverse addiction ... of Neuroscience , Michigan State University neuroscientist A.J. Robison ... brain,s pleasure center that responds to stimuli such as ...
... can literally be the difference between life and death. ... stood out starkly against the light-colored, sandy soil, making them ... the mice evolved a new system of camouflage lighter ... in the extent of pigment across their body that ...
... Pilot whales that have died in mass strandings ... at each event, a new study concludes, challenging a ... beach and to almost certain death because of familial ... strandings, scientists have determined that both related and unrelated ...
Cached Biology News:Discovery could yield treatment for cocaine addicts 2One gene, many mutations 2One gene, many mutations 3Study questions the role of kinship in mass strandings of pilot whales 2Study questions the role of kinship in mass strandings of pilot whales 3
Conveniently document gels, films and membranes with a high quality thermal printer. , Compact, footprint printer , Supplies 256 gray scale for high resolution, archive-quality thermal film prints...
Rabbit Polyclonal antibody to Perilipin Applications: This antibody is useful for Western blot anlaysis where a band at ~60 kDa is seen....
Conveniently document gels, films and membranes with a high quality thermal printer. , Compact, footprint printer , Supplies 256 gray scale for high resolution, archive-quality thermal film prints...
... designer enzyme that enables RT-PCR in ... enzyme allows reverse transcription and PCR ... temperatures (65C), which helps to remove ... results in highly stringent, accurate annealing ...
Biology Products: